LEG
16
5
VLO
39
11
SRE
50
-2
BK
72
3
EXC
45
-6
T
44
2
MTCH
42
-11
JCI
36
3
RIG
49
6
UA
33
-2
NI
60
2
MAS
64
12
WHR
42
2
OI
41
4
GD
66
2
FLS
68
3
PRGO
65
3
BF.B
50
-4
MS
74
2
YUM
56
2
LEG
16
5
VLO
39
11
SRE
50
-2
BK
72
3
EXC
45
-6
T
44
2
MTCH
42
-11
JCI
36
3
RIG
49
6
UA
33
-2
NI
60
2
MAS
64
12
WHR
42
2
OI
41
4
GD
66
2
FLS
68
3
PRGO
65
3
BF.B
50
-4
MS
74
2
YUM
56
2
Financhill
Back

Avidity Biosciences 10K Form

Buy
55

RNA
Avidity Biosciences

Last Price:
25.12
Seasonality Move:
4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RNA News And Ratings

See the #1 stock for the next 7 days that we like better than RNA

RNA Financial Statistics

Sales & Book Value

Annual Sales: $9.56M
Cash Flow: $15.64M
Price / Cash Flow: 0
Annual Sales: $6.32
Price / Book: 4.19

Profitability

EPS (TTM): -2.91000
Net Income (TTM): $-212.22M
Gross Margin: $8.9M
Return on Equity: -39.09%
Return on Assets: -34.62%

Avidity Biosciences Earnings Forecast

Key Avidity Biosciences Financial Ratios

  • The Gross Profit Margin over the past 1 years for RNA is 100.00%.
  • The Selling, General & Administrative Expenses for RNA have been equal to 566.84% of Gross Profit Margin.
  • The Research & Development expenses have been 1,997.57% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of RNA is -2,219.87% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Avidity Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RNA
CUSIP: 05370A
Website: aviditybiosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.58
Quick Ratio: 7.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RNA Technical Analysis vs Fundamental Analysis

Buy
55
Avidity Biosciences (RNA) is a Buy

Is Avidity Biosciences a Buy or a Sell?